These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 13588186)
1. Cardiac complications in patients with nontoxic and toxic nodular goiter and with Graves' disease. BERTEAU BA; ENGSTROM WW; ENGBRING NH J Lab Clin Med; 1958 Nov; 52(5):687-93. PubMed ID: 13588186 [No Abstract] [Full Text] [Related]
2. Increased Cardiovascular Mortality and Morbidity in Patients Treated for Toxic Nodular Goiter Compared to Graves' Disease and Nontoxic Goiter. Giesecke P; Rosenqvist M; Frykman V; Friberg L; Wallin G; Höijer J; Lönn S; Törring O Thyroid; 2017 Jul; 27(7):878-885. PubMed ID: 28471268 [TBL] [Abstract][Full Text] [Related]
3. Influence of smoking on Graves' disease with or without ophthalmopathy and nontoxic nodular goiter in Taiwan. Chen YL; Chang TC; Chen CJ J Formos Med Assoc; 1994 Jan; 93(1):40-4. PubMed ID: 7915579 [TBL] [Abstract][Full Text] [Related]
4. [Hyperthyroidism and carcinoma of the thyroid gland]. Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859 [TBL] [Abstract][Full Text] [Related]
5. Familial risks for hospitalized Graves' disease and goiter. Hemminki K; Shu X; Li X; Ji J; Sundquist K; Sundquist J Eur J Endocrinol; 2009 Oct; 161(4):623-9. PubMed ID: 19661127 [TBL] [Abstract][Full Text] [Related]
7. Smoking as a risk factor for Graves' disease, toxic nodular goiter, and autoimmune hypothyroidism. Vestergaard P; Rejnmark L; Weeke J; Hoeck HC; Nielsen HK; Rungby J; Laurberg P; Mosekilde L Thyroid; 2002 Jan; 12(1):69-75. PubMed ID: 11838733 [TBL] [Abstract][Full Text] [Related]
8. [On an unusual electrocardiographic aspect of hyperthyroidism: the Sr' complex in lead V 1]. Carenza P; Busnardo B Cardiol Prat; 1968 Aug; 19(4):277-84. PubMed ID: 5757559 [No Abstract] [Full Text] [Related]
9. Surgical management of hyperthyroidism. Quérat C; Germain N; Dumollard JM; Estour B; Peoc'h M; Prades JM Eur Ann Otorhinolaryngol Head Neck Dis; 2015 Apr; 132(2):63-6. PubMed ID: 25592327 [TBL] [Abstract][Full Text] [Related]
10. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism]. Bürgi U; Gerber H; Peter HJ Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825 [TBL] [Abstract][Full Text] [Related]
11. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. Franklyn JA; Daykin J; Holder R; Sheppard MC QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667 [TBL] [Abstract][Full Text] [Related]
12. Total thyroidectomy: is morbidity higher for Graves' disease than nontoxic goiter? Welch KC; McHenry CR J Surg Res; 2011 Sep; 170(1):96-9. PubMed ID: 21550063 [TBL] [Abstract][Full Text] [Related]
13. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease). Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064 [TBL] [Abstract][Full Text] [Related]
14. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679 [TBL] [Abstract][Full Text] [Related]
15. Toxic multinodular goiter: a variant of autoimmune hyperthyroidism. Kraiem Z; Glaser B; Yigla M; Pauker J; Sadeh O; Sheinfeld M J Clin Endocrinol Metab; 1987 Oct; 65(4):659-64. PubMed ID: 2888784 [TBL] [Abstract][Full Text] [Related]